Promoting BEST (BEtter, Faster, Longer, STronger) Walking for People With Parkinson's

Last updated: March 24, 2023
Sponsor: Nancy Mayo
Overall Status: Active - Enrolling

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05801926
A00-B37-22A / eRAP 22-04-037
  • Ages > 18
  • All Genders

Study Summary

This project aims to improve how people with Parkinson's Disease (PD) walk. The global aim is to identify obstacles and solutions for people with PD for adopting technology to track and improve their gait to make them better and safer walkers. To meet this aim members of Parkinson Quebec will be surveyed about their technology readiness, physical, cognitive, and psychological health, and rehabilitation access. The survey should not take more than 20 minutes to complete on the web. Subsequently, a random sample of 100 survey participants will be offered a wearable device, the Heel2ToeTM sensor, designed to improve gait quality. This device emits a beep when a proper step is taken. This external cue reinforces the adoption of an adequate gait. In addition to the device, participants will be offered 5 sessions of telemonitoring to help them use the device optimally. Monitoring of use and outcomes will be over 3 months and the sensor is theirs to keep.

Eligibility Criteria

Inclusion

Inclusion Criteria: Technology readiness will be determined by the following criteria:

  • has wifi
  • has a smartphone that is recent enough to support the technology or willing to acquireone
  • uses apps on the smartphone on most days of the week with or without the aid ofanother person
  • positively endorses the question "Are you interested in learning new things?"58 and "Iwalk outdoors on most days, weather permitting." To screen participants for their capacity to use the Heel2Toe sensor, participants meetingthe technology readiness criteria will be instructed to send a smartphone video ofthemselves doing a modified Timed-up-an-Go test65 in which the person, stands up from achair, walks minimum of 10 meters (original TUG is 3 m.), turns, walks back to the chair,and sits down (long-TUG).

Exclusion

Exclusion Criteria:

  • unable to do the long TUG without assistance or need for a walking aid
  • unable to recover balance independently from a perturbation during execution of thelong TUG
  • unable to reinitiate movement without assistance or without losing balance during afreezing event occurring during the long TUG. -

Study Design

Total Participants: 100
Study Start date:
January 31, 2023
Estimated Completion Date:
January 31, 2024

Study Description

The global aim of this research program is to identify technical, attitudinal, and motivational obstacles and solutions for people with PD for adopting technology to improve gait and to quantify changes in gait biomechanics that will make participants better and safer walkers, ultimately improving physical function, physical activity, motivation, and quality of life.

Specific objective: Among members of the PQ who meet the criteria for technology readiness and have sufficient walking capacity to use the Heel2ToeTM sensor at home, the objectives are to estimate the extent to which they: (1) require support from the technology and rehabilitation team to optimize use; (2) use the sensor; (3) and change gait pattern, walking behaviours, motivation and functional and quality of life indicators over a period of 3 months.

Design: An individualized, blocked, stepped-wedge design will be used, a design favoured for implementation science questions 63,64 and applicable here as the team does not have the resources to implement the technology to all participants all at once. Parkinson Quebec has provided funds to provide sensors for 100 people. Variable size clusters of people will be formed and randomized to receive the Heel2Toe sensor, training, and remote supervised use, at intervals of 3 weeks. The cluster size will be randomly determined ranging from 4 to 10. As everyone selected for the implementation have already filled out the survey, there is a common data set at project entry. This assessment will be repeated prior to being entered into the Heel2Toe phase and then 3 months later.

Connect with a study center

  • Division of Clinical Epidemiology

    Montreal, Quebec H3A 1A1
    Canada

    Site Not Available

  • Research Institute of the McGill University Health Center, CORE, 5252 de Maisonneuve

    Montréal, Quebec H4A 3S5
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.